Combined products

Technological advances are increasingly allowing the development of combined products from pharma, medtech and tech companies as a basis for tailored and innovative healthcare solutions.


MPP defines combined products as the intersection of any devices or diagnostics with drugs (including biologics) for medical purpose.

Examples are:

  • A drug and device are integral (but not reusable) and classified as a drug

  • A device and drug are integral, but where the action of the drug is ancillary

  • A device and a human blood-derived substance (ancillary) are integral

  • A device is combined with an Advanced Therapy Medicinal Product (ATMP)

  • A companion diagnostic (CDx) is used with drug

  • A drug is combined with the use of e-health/m-health products